TABLE 3.
Multivariate analysis for risk of hip fracture and HT use
Risk factors | Hazard ratio (95% CI) | P |
---|---|---|
Model 1 | ||
No HT use in the previous yeara | 1.55 (1.36–1.77) | <0.0001 |
Race | ||
White | 1.0 | |
Black | 0.51 (0.38–0.69) | <0.0001 |
Hispanic | 0.74 (0.60–0.91) | |
Asian | 0.44 (0.31–0.63) | |
Unknown | 0.30 (0.24–0.37) | |
Other | 0.51 (0.19–1.37) | |
Age (5-y increment) | 1.97 (1.89–2.05) | <0.0001 |
Model 2 (adjusted for age and race) | ||
Total no. of years not on HT after 2002a | <0.0001 | |
0 | 1.0 | |
1 | 1.16 (0.96–1.40) | |
2 | 1.52 (1.26–1.84) | |
3 | 1.64 (1.34–2.00) | |
4 | 1.68 (1.36–2.08) | |
≥5 | 1.77 (1.44–2.18) |
HT, hormone therapy.
Variables considered time-dependent in Cox regression model.